Celltrion, Foreign Investors Net Buy 84,538 Shares... Stock Price Up 2.6%
As of 2:32 PM on the 25th, Celltrion is trading at 256,500 KRW, up 2.6% from the previous day. This is a 19.34% decrease compared to September 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.
Today, foreigners have a tentative net purchase of 84,538 shares of Celltrion, and institutions have a net purchase of 14,000 shares. Over the past five days, individual investors have net purchased 1,597 shares, while foreigners and institutions have net purchased 232,099 shares and net sold 234,412 shares, respectively.
On September 18, Celltrion was a market issue due to the "approval news of Phase 2 and 3 clinical trials for the COVID-19 treatment," which caused its stock price to rise.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
